The North American Spine Society (NASS) is pleased to announce publication of the recently revised Coverage Recommendations on Recombinant Human Bone Morphogenetic Protein BMP-2. NASS continues to develop and update Coverage Recommendations for various spine care procedures, treatments and diagnostics (30+ topics currently available).

Dr. Eeric Truumees, along with NASS’ multidisciplinary and evidence-based medicine trained team of spine specialists, spent a significant amount of time reviewing the evidence and developing this valuable resource.

This topic and related coverage recommendations have undergone a thorough review by NASS. More detailed indications/contraindications are further delineated in the full coverage document. 

Please click here to access your copy of the Recombinant Human Bone Morphogenetic Protein BMP-2 Coverage Recommendations.

NASS’ coverage documents continue to be utilized by government agencies, third-party payors, utilization management groups, spine care providers, and patients across the nation. We hope these coverage recommendations continue to help provide access to appropriate spine care for all patients affected by spine problems and their sequelae.

NASS would like to thank Dr. Truumees and the entire Coverage Committee for their continued efforts and dedication!